Evidence map›Paper›PMID 41387007›Full record

ArticleBMJ open2025

Impact of COVID-19 on the detection of tuberculosis in Guangdong, China based on the autoregressive integrated moving average model: a time-series study.

Ruilong Wang, Fangjing Zhou, Guoqi Shi, Yuan Liu, Ying Bian, Huizhong Wu, Guanyang Zou

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruilong WangSchool of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Fangjing ZhouGuangdong Provincial Centre for Tuberculosis Control, Guangzhou, Guangdong, China.
Guoqi ShiSchool of Foreign Studies, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Yuan LiuCentre for Disease Prevention and Control, Liwan District, Guangzhou, Guangdong, China.
Ying BianState Key Laboratory of Quality Research in Chinese Medicine, University of Macau Institute of Chinese Medical Sciences, Taipa, Macao.ORCID http://orcid.org/0000-0002-1716-2925
Huizhong WuGuangdong Provincial Centre for Tuberculosis Control, Guangzhou, Guangdong, China Gzou2023@outlook.com 1627639699@qq.com.
Guanyang ZouSchool of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China Gzou2023@outlook.com 1627639699@qq.com.ORCID http://orcid.org/0000-0001-6933-2749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChina has continued to improve tuberculosis (TB) control in the past decade; however, the sudden outbreak of COVID-19 hindered this progress. As a province with a large population and frequent international exchanges, Guangdong has been seriously affected by COVID-19. This study aimed to understand the effect of COVID-19 on TB detection in Guangdong based on the autoregressive integrated moving average (ARIMA) model.

designTime-series study.

settingGuangdong, China. OUTCOME MEASURES: We used the ARIMA model to quantify the effect of COVID-19 by comparing reported cases during the COVID-19 pandemic with predicted cases under a counterfactual scenario of no COVID-19 pandemic. After model evaluation, we chose ARIMA (0,1,2)(0,1,1)

resultsDuring the pandemic period, the average annual TB notification rate was 57.95/100 000, which decreased by 27.97% compared with the pre-pandemic period. Although it decreased by 6.17% on average annually in the pre-pandemic period, it decreased by 14.92% in 2020 as compared with 2019, but only decreased by 0.34% in 2021 as compared with 2020. The results of the ARIMA model showed that the number of reported cases in 2020 decreased by 6.62% compared with that of the predicted cases, but this decreased by 0.42% only in 2021. The most seriously affected period was the second-level emergency response period in 2020, when the relative difference between reported and predicted cases reached the peak (-16.43%). The least affected period was the third-level emergency response period of 2021, the reported cases recovered and exceeded the predicted cases, with a gap of 0.77%.

conclusionsTB detection in Guangdong had generally declined during the COVID-19 pandemic, which might be related to the movement restrictions, diverted resources and patients' concerns. This decline would lead to the delay or even interruption of diagnosis and treatment, which would cause the regression of TB control. To improve TB detection, it is important for stakeholders to take consorted effort during public health emergencies.

Indexed as

COVID-19TuberculosisChinaHumansModels, StatisticalPandemicsSARS-CoV-2ChinaCOVID-19Tuberculosis

Identifiers

PMID41387007
PMCPMC12706103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.